Manitoba-based virologists think province should continue with AstraZeneca rollout despite concerns

Despite concerns overseas over potential adverse side effects linked to the Oxford-AstraZeneca COVID-19 vaccine, Manitoba-based virologists say the province shouldn’t suspend using the product in its vaccine rollout. View original article here Source